{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:02:35Z","timestamp":1789574555616,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deutsche Forschungs-gemeinschaft","award":["BU 1141\/7-1"],"award-info":[{"award-number":["BU 1141\/7-1"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.yexmp.2015.01.010","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T03:44:43Z","timestamp":1421207083000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Reduced serum chemerin in patients with more severe liver cirrhosis"],"prefix":"10.1016","volume":"98","author":[{"given":"Kristina","family":"Eisinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2015.01.010_bb0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/gut.52.6.879","article-title":"Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt","volume":"52","author":"Angermayr","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/en.2010-1157","article-title":"Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes","volume":"152","author":"Bauer","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.regpep.2012.08.007","article-title":"Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury","volume":"179","author":"Bauer","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-230X-11-107","article-title":"The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS)","volume":"11","author":"Benten","year":"2011","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/gut.52.1.134","article-title":"MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study","volume":"52","author":"Botta","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0030","first-page":"2801","article-title":"Adiponectin, a key adipokine in obesity related liver diseases","volume":"17","author":"Buechler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-13-0112","article-title":"Elevated hepatic chemerin gene expression in progressed human non-alcoholic fatty liver disease","volume":"169","author":"Docke","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0040","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/eci.12122","article-title":"Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension","volume":"43","author":"Eisinger","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/bjd.12118","article-title":"Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab","volume":"168","author":"Gisondi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0050","doi-asserted-by":"crossref","first-page":"e96345","DOI":"10.1371\/journal.pone.0096345","article-title":"Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice","volume":"9","author":"Gruben","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10641963.2013.827697","article-title":"Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients","volume":"36","author":"Gu","year":"2014","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0060","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/gut.2010.234542","article-title":"Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS","volume":"60","author":"Holland-Fischer","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.diabres.2010.11.016","article-title":"Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients","volume":"91","author":"Hu","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0070","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.3390\/ijms150711294","article-title":"Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma","volume":"15","author":"Imai","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","article-title":"Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver","volume":"95","author":"Krautbauer","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365520903443852","article-title":"Serum chemerin and vaspin in non-alcoholic fatty liver disease","volume":"45","author":"Kukla","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0090","doi-asserted-by":"crossref","first-page":"517820","DOI":"10.1155\/2014\/517820","article-title":"Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C","volume":"2014","author":"Kukla","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0095","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1478-3231.2005.01163.x","article-title":"Portal hypertension: from pathophysiology to clinical practice","volume":"25","author":"Laleman","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0100","first-page":"879","article-title":"Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma","volume":"57","author":"Lin","year":"2011","journal-title":"Clin. Lab."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-014-2704-1","article-title":"Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade","author":"Makrilakis","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000329799","article-title":"Modulation of liver fibrosis by adipokines","volume":"29","author":"Marra","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12072-008-9100-3","article-title":"Pathogenetic background for treatment of ascites and hepatorenal syndrome","volume":"2","author":"Moller","year":"2008","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0120","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.3748\/wjg.v20.i25.8061","article-title":"Clinical relevance of sarcopenia in patients with cirrhosis","volume":"20","author":"Montano-Loza","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000323928","article-title":"Pathophysiology of non-alcoholic steatohepatitis and basis for treatment","volume":"29","author":"Pinzani","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","article-title":"Liver cirrhosis","volume":"25","author":"Pinzani","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ncpgasthep0186","article-title":"Mechanisms of disease: adipocytokines and visceral adipose tissue\u2014emerging role in nonalcoholic fatty liver disease","volume":"2","author":"Schaffler","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0145","first-page":"428","article-title":"The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects","volume":"36","author":"Sledzinski","year":"2013","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0150","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0155","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","article-title":"Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status","volume":"51","author":"Wadhawan","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0160","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","article-title":"Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes","volume":"72","author":"Weigert","year":"2010","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl 3","key":"10.1016\/j.yexmp.2015.01.010_bb0165","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1097\/MCG.0b013e318157cb57","article-title":"Splanchnic and systemic vasodilation: the experimental models","volume":"41","author":"Wiest","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cyto.2010.06.013","article-title":"Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis","volume":"53","author":"Wiest","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.yexmp.2015.01.010_bb0175","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00365521.2010.516452","article-title":"Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"46","author":"Yilmaz","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0185","first-page":"1","article-title":"Chemerin regulation and role in host defense","volume":"3","author":"Zabel","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"10.1016\/j.yexmp.2015.01.010_bb0190","doi-asserted-by":"crossref","first-page":"39520","DOI":"10.1074\/jbc.M111.258954","article-title":"Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma","volume":"286","author":"Zhao","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448001500012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448001500012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T17:48:22Z","timestamp":1566236902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448001500012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S001448001500012X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.01.010","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced serum chemerin in patients with more severe liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}